Yu V L, Oakes C A, Axnick K J, Merigan T C
Am J Med. 1979 Mar;66(3):468-72. doi: 10.1016/0002-9343(79)91074-x.
One hundred forty nosocomial Serratia marcescens infections (including 76 cases of bacteremia) were identified by prospective surveillance from 1975 through 1977 and retrospective chart review from 1968 through 1974. Thirty-four cases (24 per cent) involved gentamicin-resistant strains. All gentamicin-resistant strains appeared after 1974. Ninety per cent of the patients had undergone surgery, and 88 per cent had received prior antimicrobial therapy. The emergence of gentamicin-resistant S. marcescens paralleled the increase in usage of gentamicin. Prior use of gentamicin for more than two days in an individual patient was a significant risk factor (P = 0.0002) for being infected with a Serratia that was gentamicin-resistant. Other factors which separated gentamicin-resistant Serratia infections from gentamicin-sensitive Serratia infections were (1) urinary site of infection (P = 0.0005), (2) urinary catheter (P = 0.002), (3) endotracheal tube or tracheotomy (P = 0.03) and (4) increasing duration of hospitalization (P less than 0.05). Thirty-three of 34 (97 per cent) patients with gentamicin-resistant strains had urinary catheters. Specific measures to control infection were effective in decreasing the incidence of infections caused by gentamicin-resistant Serratia.
通过1975年至1977年的前瞻性监测以及1968年至1974年的回顾性病历审查,共识别出140例医院内粘质沙雷氏菌感染(包括76例菌血症)。34例(24%)涉及对庆大霉素耐药的菌株。所有对庆大霉素耐药的菌株均出现在1974年之后。90%的患者接受过手术,88%的患者此前接受过抗菌治疗。对庆大霉素耐药的粘质沙雷氏菌的出现与庆大霉素使用量的增加同步。在个体患者中,先前使用庆大霉素超过两天是感染对庆大霉素耐药的沙雷氏菌的一个重要危险因素(P = 0.0002)。将对庆大霉素耐药的沙雷氏菌感染与对庆大霉素敏感的沙雷氏菌感染区分开来的其他因素包括:(1)感染部位为泌尿系统(P = 0.?005),(2)使用导尿管(P = 0.002),(3)使用气管内导管或进行气管切开术(P = 0.03)以及(4)住院时间延长(P < 0.05)。34例对庆大霉素耐药菌株的患者中有33例(97%)使用了导尿管。控制感染的具体措施有效地降低了由对庆大霉素耐药的粘质沙雷氏菌引起的感染发生率。
原文中“P = 0.?005”处疑似有误,翻译时保留原文形式。